CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hemispherx Biopharma, Inc. Company Snapshot
Hemispherx Biopharma, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hemispherx Biopharma with three other pharmaceutical manufacturers in North America: Vitality Products Inc of Canada (2016 sales of 108,486.00 Canadian Dollars [US$87,207.56 ] ), Cara Therapeutics Inc ($86,000.00 of which 100% was Pharmaceutical), and RegeneRx Biopharmaceuticals, Inc. ($93,308.00 ).

Sales Analysis. Hemispherx Biopharma reported sales of $92,000.00 for the year ending December of 2016. This represents a sharp decrease of 30.8% versus 2015, when the company's sales were $133,000.00 .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hemispherx Biopharma, Inc.
  Stock Performance Chart for Hemispherx Biopharma, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): .49
(Figures in U.S. Dollars)
1 Week -6.5%   13 Weeks 33.1%  
4 Weeks 51.2%   52 Weeks -28.8%  
 
Hemispherx Biopharma, Inc. Key Data:
  Ticker: HEB Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 92,000
(Year Ending Jan 2017).
Employees: 32
  Currency: U.S. Dollars Market Cap: 15,662,310
  Fiscal Yr Ends: December Shares Outstanding: 31,866,347
  Share Type: Common Closely Held Shares: 1,398,219
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.